The research teams of Prof. Ning Jiao reported a new breakthrough in the carbon-carbon bond fracture transformation reaction in Science.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2025, v. 34, n. 3, p. 302
- Publication type:
- Article
Works matching IS 10031057 AND DT 2025 AND VI 34 AND IP 3
Results: 12
1
2
The research teams of Prof. Haiyan Xie and Prof. Weidong Nie proposed a new strategy to induce the concurrent tertiary lymphoid structure de novo neogenesis by activating intratumoral antigen-presenting cells.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2025, v. 34, n. 3, p. 300
- Publication type:
- Article
3
The research team of Prof. Demin Zhou has made new progress in the field of recombinant adeno-associated virus vectors.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2025, v. 34, n. 3, p. 299
- Publication type:
- Article
4
Meta-analysis of the clinical efficacy of wax therapy combined with conventional pharmacotherapy in rheumatoid arthritis treatment.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2025, v. 34, n. 3, p. 284, doi. 10.5246/jcps.2025.03.022
- By:
- Publication type:
- Article
5
The research team of Prof. Liqin Zhang developed a functional oligonucleotides evolution platform targeting protein degradation.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2025, v. 34, n. 3, p. 293
- Publication type:
- Article
6
Synthesis and in vitro/in vivo assessment of sustained-release oral oseltamivir phosphate suspension.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2025, v. 34, n. 3, p. 269, doi. 10.5246/jcps.2025.03.021
- By:
- Publication type:
- Article
7
Advancing pediatric drug development in China: implementation of the national priority R&D encouragement list.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2025, v. 34, n. 3, p. 260, doi. 10.5246/jcps.2025.03.020
- By:
- Publication type:
- Article
8
Elucidating the mechanism of Kuwanon G in treating diabetic encephalopathy through network pharmacology: A comprehensive study.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2025, v. 34, n. 3, p. 251, doi. 10.5246/jcps.2025.03.019
- By:
- Publication type:
- Article
9
Bibliometric analysis of PCSK9 inhibitors for cardiovascular disease management based on Web of Science.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2025, v. 34, n. 3, p. 232, doi. 10.5246/jcps.2025.03.018
- By:
- Publication type:
- Article
10
Analysis of 979 cases of adverse drug reactions induced by antineoplastic drugs.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2025, v. 34, n. 3, p. 223, doi. 10.5246/jcps.2025.03.017
- By:
- Publication type:
- Article
11
Synthesis and functional evaluation of low-molecular-weight dextran sulfate as an inhibitor of TGF-β1-induced epithelial-to-mesenchymal transition in A549 cells.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2025, v. 34, n. 3, p. 210
- By:
- Publication type:
- Article
12
Study on chemical constituents from ethanol extract of Cyclocarya paliurus.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2025, v. 34, n. 3, p. 195, doi. 10.5246/jcps.2025.03.015
- By:
- Publication type:
- Article